Raia Drogasil S.A. (OTCMKTS:RADLY) Stock Short Interest Report for October

Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) saw a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 7,347 shares, a growth of 826.5% from the October 15th total of 793 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 44,458 shares, the short-interest ratio is currently 0.2 days.

Raia Drogasil Stock Performance

RADLY stock traded down $0.06 during trading on Thursday, hitting $2.62. 7,372 shares of the company traded hands, compared to its average volume of 81,518. Raia Drogasil has a 1 year low of $2.61 and a 1 year high of $5.34. The company has a market cap of $3.45 billion and a PE ratio of 17.47. The stock’s 50-day simple moving average is $3.60 and its 200 day simple moving average is $4.01. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.41 and a quick ratio of 0.58.

Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The business had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.43 billion. Raia Drogasil had a return on equity of 20.61% and a net margin of 2.89%. On average, equities analysts expect that Raia Drogasil will post 0.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised Raia Drogasil to a “buy” rating and set a $5.20 price target on the stock in a research report on Sunday, October 18th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $5.20.

Get Our Latest Stock Report on Raia Drogasil

About Raia Drogasil

(Get Free Report)

Raia Drogasil, now known as RD Saúde, is a Brazilian health and pharmacy retail company formed in 2011 through the merger of Droga Raia and Drogasil. It operates pharmacy stores under the Raia and Drogasil brands. The company sells prescription and over-the-counter medicines, personal care and beauty products, and other health and wellness goods. It serves customers across Brazil through its retail locations and digital channels, including online ordering and delivery. In addition to pharmacy retail, RD Saúde provides health-related services through its stores and digital platforms.

See Also

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.